Reaction
Urogenital Fistula reporting signals
As of the last recalculation, Urogenital Fistula appears in 231 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is PACLITAXEL (AIBUMIN-BOUND) (PRR 90.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Paclitaxel (Aibumin-Bound) | 61 | 90.5 | 90.6 |
| Paclitaxel | 63 | 78.4 | 78.5 |
| Pembrolizumab | 62 | 72.2 | 72.3 |
| Bevacizumab | 68 | 69.7 | 69.7 |
| Cisplatin | 35 | 47.4 | 47.4 |
| Lenvatinib | 16 | 47.1 | 47.2 |
| Carboplatin | 50 | 45.0 | 45.0 |